BioPharmX to Report First Quarter Financial Results on June 14, 2016
MENLO PARK, Calif., June 7, 2016 /PRNewswire/ -- BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical company focusing on dermatology and women's health, today announced that it will release its financial results for the fiscal first quarter ended April 30, 2016 after the close of trading on Tuesday, June 14, 2016. The company's management team will host a corresponding conference call beginning at 1:30 p.m. PDT/4:30 p.m. EDT.
Individuals interested in listening to the conference call may do so by dialing (866) 652-5200 (domestic) or (412) 317-6011 (international), and requesting to join the BioPharmX Corporation call. To listen to a live webcast, please visit the investors section of the BioPharmX website at http://biopharmx.investorroom.com.
MENLO PARK, Calif., June 7, 2016 /PRNewswire/ -- BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical company focusing on dermatology and women's health, today announced that it will release its financial results for the fiscal first quarter ended April 30, 2016 after the close of trading on Tuesday, June 14, 2016. The company's management team will host a corresponding conference call beginning at 1:30 p.m. PDT/4:30 p.m. EDT.
Individuals interested in listening to the conference call may do so by dialing (866) 652-5200 (domestic) or (412) 317-6011 (international), and requesting to join the BioPharmX Corporation call. To listen to a live webcast, please visit the investors section of the BioPharmX website at http://biopharmx.investorroom.com.